Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
BIOLASE (BIOLQ)
OTHER OTC:BIOLQ
Holding BIOLQ?
Track your performance easily
BIOLQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $1.27
Previous Close$0.02
Volume28.50K
Average Volume (3M)355.90K
Market Cap
$274.48K
Enterprise Value$13.08M
Total Cash (Recent Filing)$3.44M
Total Debt (Recent Filing)$16.25M
Price to Earnings (P/E)―
Beta-0.63
Next Earnings
Mar 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-7.85
Shares Outstanding36,597,334
10 Day Avg. Volume106,430
30 Day Avg. Volume355,905
Standard Deviation0.36
R-Squared0.02
Alpha-0.12
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)-0.05
Price to Sales (P/S)0.01
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.30
Enterprise Value/Gross Profit0.78
Enterprise Value/Ebitda-1.31
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
BIOLASE News
PremiumCompany Announcements
Biolase Inc. Faces Bankruptcy Amid Strategic Asset Sale
Ownership Overview
0.60%
Insiders
0.01% Mutual Funds
0.44% Other Institutional Investors
98.94% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BIOLQ FAQ
What was BIOLASE’s price range in the past 12 months?
BIOLASE lowest stock price was <$0.01 and its highest was $1.27 in the past 12 months.
What is BIOLASE’s market cap?
Currently, no data Available
When is BIOLASE’s upcoming earnings report date?
BIOLASE’s upcoming earnings report date is Mar 26, 2025 which is in 94 days.
How were BIOLASE’s earnings last quarter?
BIOLASE released its earnings results on Nov 06, 2024. The company reported -$0.038 earnings per share for the quarter, beating the consensus estimate of -$0.08 by $0.042.
Is BIOLASE overvalued?
According to Wall Street analysts BIOLASE’s price is currently Overvalued.
Does BIOLASE pay dividends?
BIOLASE does not currently pay dividends.
What is BIOLASE’s EPS estimate?
BIOLASE’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does BIOLASE have?
BIOLASE has 36,597,336 shares outstanding.
What happened to BIOLASE’s price movement after its last earnings report?
BIOLASE reported an EPS of -$0.038 in its last earnings report, beating expectations of -$0.08. Following the earnings report the stock price went down -16.667%.
Which hedge fund is a major shareholder of BIOLASE?
Currently, no hedge funds are holding shares in BIOLQ
---
BIOLASE Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-29.69%
Trailing 12-Months
Company Description
BIOLASE
BIOLASE, Inc. is a medical device company, which engages in the development, manufacture, market and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.
---
BIOLQ Earnings Call
Q1 2024
0:00 / 0:00
---
BIOLQ Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering BIOLQ
1 Year
1 Year Success Rate
1/11 ratings generated profit
1 Year Average Return
-71.57%
reiterated a buy rating 4 months ago
Copying Edward Woo's trades and holding each position for 1 Year would result in 9.09% of your transactions generating a profit, with an average return of -71.57% per trade.
---